Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-19
DOI
10.3389/fimmu.2020.01021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
- (2019) I-Yin Chen et al. Frontiers in Microbiology
- Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC
- (2019) Kam-Leung Siu et al. FASEB JOURNAL
- Pathogenesis of Acute Respiratory Distress Syndrome
- (2019) Laura Huppert et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- RNA viruses promote activation of the NLRP3 inflammasome through cytopathogenic effect-induced potassium efflux
- (2019) Leandro Silva da Costa et al. Cell Death & Disease
- Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases
- (2018) Yi Huang et al. EMBO Molecular Medicine
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis
- (2018) Carlos Castaño-Rodriguez et al. mBio
- Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
- (2018) Hongbin He et al. Nature Communications
- Regulation of the NLRP3 inflammasome and macrophage pyroptosis by the p38 MAPK signaling pathway in a mouse model of acute lung injury
- (2018) Dandan Li et al. Molecular Medicine Reports
- SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death
- (2018) Yuan Yue et al. Cell Death & Disease
- Anti-Inflammatory Effects of Colchicine on Oxidised Low-Density Lipoproteins and Cholesterol Crystal-Induced Macrophage Activation in vitro
- (2017) S. Fernando et al. Heart Lung and Circulation
- Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
- (2017) Hua Jiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- BOT-4-one attenuates NLRP3 inflammasome activation: NLRP3 alkylation leading to the regulation of its ATPase activity and ubiquitination
- (2017) Do-Wan Shim et al. Scientific Reports
- Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo
- (2016) Hussin A. Rothan et al. ANTIVIRAL RESEARCH
- Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation
- (2016) S. Robertson et al. CLINICAL SCIENCE
- Alterations in immune function with biologic therapies for autoimmune disease
- (2016) Minyoung Her et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS
- (2016) Yong Hwan Park et al. NATURE IMMUNOLOGY
- Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation
- (2016) Hanne Van Gorp et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models
- (2016) Michael J. D. Daniels et al. Nature Communications
- Colchicine prevents NSAID-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasome
- (2016) Koji Otani et al. Scientific Reports
- Initiation and perpetuation of NLRP3 inflammasome activation and assembly
- (2015) Eric I. Elliott et al. IMMUNOLOGICAL REVIEWS
- The Acute Respiratory Distress Syndrome: From Mechanism to Translation
- (2015) SeungHye Han et al. JOURNAL OF IMMUNOLOGY
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Colchicine—Update on mechanisms of action and therapeutic uses
- (2015) Ying Ying Leung et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome
- (2015) Jose L. Nieto-Torres et al. VIROLOGY
- Critical Role for the NLRP3 Inflammasome during Acute Lung Injury
- (2014) J. J. Grailer et al. JOURNAL OF IMMUNOLOGY
- Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis
- (2014) Jose L. Nieto-Torres et al. PLoS Pathogens
- The NLRP3 Inflammasome is Required for the Development of Hypoxemia in LPS/Mechanical Ventilation Acute Lung Injury
- (2013) Heather D Jones et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Targeting the “Cytokine Storm” for Therapeutic Benefit
- (2013) Riccardo V. D'Elia et al. Clinical and Vaccine Immunology
- Inhibition of NF- B-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival
- (2013) M. L. DeDiego et al. JOURNAL OF VIROLOGY
- Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome
- (2013) Takuma Misawa et al. NATURE IMMUNOLOGY
- Viroporins: structure and biological functions
- (2012) José Luis Nieva et al. NATURE REVIEWS MICROBIOLOGY
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment
- (2011) Michael A. Matthay et al. Annual Review of Pathology-Mechanisms of Disease
- Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome
- (2010) Christine Juliana et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
- (2009) Mohamed Lamkanfi et al. JOURNAL OF CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now